Kate Bingham

Kate Bingham, former Chair of the UK Vaccine Taskforce and seasoned venture capitalist, shares her insights on the swift development of COVID-19 vaccines. She discusses how blending business expertise with scientific knowledge was crucial during the crisis. Bingham also dives into the challenges of rapid vaccine trials and the innovative solutions that emerged, including the establishment of a national citizen registry. Furthermore, she highlights the UK's proactive strategies for future pandemic preparedness and the role of AI in predicting viral mutations.